Sponsor Pipeline

Kodiak Sciences Inc Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
4
Phase 3
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-29 NCT07734844 A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to… Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06990399 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in… Macular Edema Secondary to Inflammation Recruiting
NCT06996080 A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in… Macular Edema Secondary to Inflammation Recruiting
NCT06556368 A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp… Wet Age-related Macular Degeneration Active, Not Recruiting
NCT07734844 A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to… Diabetic Macular Edema (DME) Not Yet Recruiting
Get alerts when Kodiak Sciences Inc's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free